POST FINASTERIDE SYNDROME (PSF)
Five alpha-reductase
inhibitors used for prostate baldness and
adenoma
can cause
irreversible damage, according to the
Post-Finasteride Syndrome Foundation. See
PowerPoint
Androgen biosynthesis is complex and is not part
of this presentation.
However, the reader can get an idea by
consulting the link below:
https://en.wikipedia.org/wiki/Androgen#Biosynthesis
More simply, by looking at
BIOCHEMICAL DIAGNOSIS
In the diagram below, we
can already understand that testosterone is a
precursor of dihydrotestosterone (that is the
sex hormone itself). Testosterone is also a
precursor of estradiol (that is the proliferative
female hormone). By preventing the production of
dihydrotestosterone, the 5-alpha-reductase
inhibitors promote the production of estradiol
and thus the male feminization .
The pituitary gland also controls these
biochemical reactions.
Believing that 5-alpha-reductase inhibitors are
the correct treatments for baldness and prostate
adenoma is simplistic and even dangerous
reasoning.
***
A man with post-finasteride syndrome must
analyze his
biology thoroughly to correct
his biochemistry.
Between 1993 and 2020,
iatrogeny has reproduced and aggravated two
pathologies :
The syndrome of prostate atrophy
(1979)
and
The androgenic disease of andropause (1988)
through the use of
5-alpha-reductase for illusory and dangerous
prescriptions